Terumo Corporation (TYO:4543)

Market Cap	3.60T
Revenue (ttm)	1.06T
Net Income (ttm)	130.67B
Shares Out	1.48B
EPS (ttm)	88.53
PE Ratio	27.56
Forward PE	23.69
Dividend	30.00 (1.23%)
Ex-Dividend Date	Mar 30, 2026

Volume	4,493,400
Average Volume	4,917,995
Open	2,400.00
Previous Close	2,424.00
Day's Range	2,380.50 - 2,440.00
52-Week Range	2,336.50 - 3,154.00
Beta	0.33
RSI	47.97
Earnings Date	Nov 12, 2025

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 28,294
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4543

Financial Performance

In 2024, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.